Inventor · disambiguated record
Marie Woolley-Roberts
Also filed as: WOOLLEY-ROBERTS MARIE
10 granted patents·12 pending applications·109 citations·filing 2017–2025
88Inventor score
Top patents by PatentIndex Score
22 records- 0198US11590087B2Cannabidiol-type cannabinoid compoundGW RES LTD·Filed 2022·Granted Feb 28, 2023·23 cites·20 claims
- 0296US11865102B2Cannabidiol preparations and its usesGW RES LTD·Filed 2021·Granted Jan 9, 2024·18 cites·30 claims
- 0396US11207292B2Cannabidiol preparations and its usesGW RES LTD·Filed 2020·Granted Dec 28, 2021·47 cites·26 claims
- 0495US11679087B2Use of cannabinoids in the treatment of Angelman syndromeGW RES LTD·Filed 2017·Granted Jun 20, 2023·18 cites·19 claims
- 0586US12396963B2Cannabidiol-type cannabinoid compoundJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2020·Granted Aug 26, 2025·1 cites·7 claims
- 0686US12364670B2Cannabidiol-type cannabinoid compoundJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2020·Granted Jul 22, 2025·1 cites·11 claims
- 0785US12383512B2Cannabidiol-type cannabinoid compoundJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2020·Granted Aug 12, 2025·1 cites·10 claims
- 0879US2024207220A1Cannabidiol preparations and its usesGW RES LTD·Filed 2023·Application pending·0 cites
- 0970US2023263744A1Use of cannabinoids in the treatment of angelman syndromeGW RES LTD·Filed 2023·Application pending·0 cites
- 1070US2021052512A1Cannabidiol preparations and its usesGW RES LTD·Filed 2019·Application pending·0 cites
- 1168US2025381152A1Cannabidiol-type cannabinoid compoundJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2025·Application pending·0 cites
- 1265US12150927B2Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disordersGW RES LTD·Filed 2020·Granted Nov 26, 2024·0 cites·6 claims
- 1359US10898462B2Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disordersGW RES LTD·Filed 2017·Granted Jan 26, 2021·0 cites·18 claims
- 1458US11752111B2Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophreniaGW RES LTD·Filed 2017·Granted Sep 12, 2023·0 cites·18 claims
- 1554US2024091241A1Use of cannabidiol preparations in the treatment of temporal lobe epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 1652US2022378738A1(+)-trans tetrahydrocannabinol ((+)-trans-thc) for use as a medicamentGW RES LTD·Filed 2020·Application pending·0 cites
- 1752US2022378715A1Use of cannabidiol preparations in the treatment of absence epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 1852US2022387377A1(+)-cis tetrahydrocannabinol ((+)-cis-thc) for use as a medicamentGW RES LTD·Filed 2020·Application pending·0 cites
- 1952US2022387350A1Cannabidivarin preparations for use as a medicamentGW RES LTD·Filed 2020·Application pending·0 cites
- 2052US2022380334A1(-) - cis tetrahydrocannabinol ((-) - cis-thc) for use as a medicamentGW RES LTD·Filed 2020·Application pending·0 cites
- 2152US2022378714A1Use of cannabidiol preparations in the treatment of fragile x syndromeGW RES LTD·Filed 2020·Application pending·0 cites
- 2246US2019070128A1Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophreniaGW RES LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie Woolley-Roberts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →